General Information of Drug (ID: DMSWFGS)

Drug Name
KD-101
Indication
Disease Entry ICD 11 Status REF
Metabolic disorder 5C50-5D2Z Phase 1 [1]
Cross-matching ID
TTD ID
D09XKO

References

1 ClinicalTrials.gov (NCT01979380) Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects. U.S. National Institutes of Health.